Company press releases

Displaying 151 - 169 of 169 results
Released Company Title Industry Topic
24 Aug 2021
22:30 CEST 		ERYTECH PHARMA ERYTECH organise un webinaire, sur eryaspase dans le cancer du pancréas, avec des leaders d'opinion 20103010 Biotechnology Meetings / events
05 Aug 2021
18:00 CEST 		ERYTECH PHARMA Monthly information related to total number of voting rights and shares composing the share capital – July 30, 2021 20103010 Biotechnology Legal
05 Aug 2021
18:00 CEST 		ERYTECH PHARMA Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 juillet 2021 20103010 Biotechnology Legal
29 Jul 2021
22:05 CEST 		ERYTECH PHARMA ERYTECH Granted U.S. FDA Fast Track Designation for Eryaspase in Hypersensitive ALL 20103010 Biotechnology Products and services
29 Jul 2021
22:05 CEST 		ERYTECH PHARMA ERYTECH reçoit la désignation Fast Track de la FDA américaine pour eryaspase dans le traitement de la LAL hypersensible 20103010 Biotechnology Products and services
27 Jul 2021
07:30 CEST 		ERYTECH PHARMA ERYTECH to Participate in the BTIG Virtual Biotechnology Conference 20103010 Biotechnology Meetings / events
27 Jul 2021
07:30 CEST 		ERYTECH PHARMA ERYTECH annonce sa participation à la conférence virtuelle BTIG Biotechnology 20103010 Biotechnology Meetings / events
21 Jul 2021
22:05 CEST 		ERYTECH PHARMA ERYTECH Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Patients 20103010 Biotechnology Products and services
21 Jul 2021
22:05 CEST 		ERYTECH PHARMA ERYTECH confirme son intention de déposer une demande de BLA pour eryaspase dans le traitement des patients atteints de LAL hypersensible 20103010 Biotechnology Products and services
06 Jul 2021
18:00 CEST 		ERYTECH PHARMA Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 Juin 2021 20103010 Biotechnology Legal
06 Jul 2021
18:00 CEST 		ERYTECH PHARMA Monthly information related to total number of voting rights and shares composing the share capital – June 30, 2021 20103010 Biotechnology Legal
25 Jun 2021
22:30 CEST 		ERYTECH PHARMA COMPTE RENDU - ASSEMBLEE GENERALE MIXTE D’ERYTECH LE 25 JUIN 2021 20103010 Biotechnology General meeting / Board Meeting
25 Jun 2021
22:30 CEST 		ERYTECH PHARMA Report - Erytech’s Combined Shareholders’ Meeting on June 25, 2021 20103010 Biotechnology General meeting / Board Meeting
07 Jun 2021
18:00 CEST 		ERYTECH PHARMA Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 Mai 2021 20103010 Biotechnology Legal
07 Jun 2021
18:00 CEST 		ERYTECH PHARMA Monthly information related to total number of voting rights and shares composing the share capital – May 31, 2021 20103010 Biotechnology Legal
26 May 2021
22:30 CEST 		ERYTECH PHARMA ERYTECH to Participate in Upcoming Virtual Investor Conferences in June 20103010 Biotechnology Meetings / events
26 May 2021
22:30 CEST 		ERYTECH PHARMA ERYTECH participera aux prochaines conférences virtuelles des investisseurs en juin 20103010 Biotechnology Meetings / events
25 May 2021
22:00 CEST 		ERYTECH PHARMA Erytech’s Combined Shareholders’ Meeting on June 25, 2021 20103010 Biotechnology General meeting / Board Meeting
25 May 2021
22:00 CEST 		ERYTECH PHARMA ASSEMBLEE GENERALE MIXTE D’ERYTECH LE 25 JUIN 2021 20103010 Biotechnology General meeting / Board Meeting